This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Michael Fenster: Innovator in Hepatitis C Treatment
Introduction
Michael Fenster is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for viral infections. His work focuses on innovative methods that can potentially improve patient outcomes.
Latest Patents
Michael Fenster holds a patent for Hepatitis C virus inhibitors. The patent details methods for making asunaprevir, which is a useful treatment for Hepatitis C virus (HCV) infection, along with its intermediates. This invention represents a crucial advancement in the fight against Hepatitis C.
Career Highlights
Michael Fenster is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical company. His role there has allowed him to work on groundbreaking research and development projects that aim to address significant health challenges.
Collaborations
Michael has collaborated with esteemed colleagues such as Scott A. Savage and Nathan R. Domagalski. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Michael Fenster's work in developing Hepatitis C treatments exemplifies the impact of innovation in medicine. His contributions are vital in advancing healthcare solutions for patients suffering from viral infections.